Literature DB >> 11237008

Cancer and genomics.

P A Futreal1, A Kasprzyk, E Birney, J C Mullikin, R Wooster, M R Stratton.   

Abstract

Identification of the genes that cause oncogenesis is a central aim of cancer research. We searched the proteins predicted from the draft human genome sequence for paralogues of known tumour suppressor genes, but no novel genes were identified. We then assessed whether it was possible to search directly for oncogenic sequence changes in cancer cells by comparing cancer genome sequences against the draft genome. Apparently chimaeric transcripts (from oncogenic fusion genes generated by chromosomal translocations, the ends of which mapped to different genomic locations) were detected to the same degree in both normal and neoplastic tissues, indicating a significant level of false positives. Our experiment underscores the limited amount and variable quality of DNA sequence from cancer cells that is currently available.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237008     DOI: 10.1038/35057046

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  Assembly of the working draft of the human genome with GigAssembler.

Authors:  W J Kent; D Haussler
Journal:  Genome Res       Date:  2001-09       Impact factor: 9.043

2.  Functional cloning, sorting, and expression profiling of nucleic acid-binding proteins.

Authors:  Y Ramanathan; Haibo Zhang; Virginie Aris; Patricia Soteropoulos; Stuart A Aaronson; Peter P Tolias
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

3.  Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents.

Authors:  XiaoHui Wang; Cheng Ji; HongHan Zhang; Yu Shan; YiJie Ren; YanWei Hu; LiangRong Shi; LingChuan Guo; WeiDong Zhu; YuJuan Xia; BeiJia Liu; ZiYun Rong; BiLian Wu; ZhiJun Ming; XingCong Ren; JianXun Song; JinMing Yang; Yi Zhang
Journal:  J Biol Chem       Date:  2019-05-17       Impact factor: 5.157

4.  Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.

Authors:  Nicole A Perry; Marey Shriver; Marie G Mameza; Bryan Grabias; Eric Balzer; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

Review 5.  The changing role of pathology in breast cancer diagnosis and treatment.

Authors:  Anthony S-Y Leong; Zhengping Zhuang
Journal:  Pathobiology       Date:  2011-06-14       Impact factor: 4.342

6.  Mining the draft human genome.

Authors:  E Birney; A Bateman; M E Clamp; T J Hubbard
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

Review 7.  Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer.

Authors:  Michelle G Zhang; John Y Lee; Ryan A Gallo; Wensi Tao; David Tse; Ravi Doddapaneni; Daniel Pelaez
Journal:  Pharmacol Res       Date:  2017-12-02       Impact factor: 7.658

Review 8.  Beyond chemotherapy: targeted therapies in ovarian cancer.

Authors:  Timothy A Yap; Craig P Carden; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

9.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

10.  CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.

Authors:  Bao-Sheng Wang; Zhen Liu; Wei-Xue Xu; Shao-Long Sun
Journal:  Tumour Biol       Date:  2013-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.